OGNNYSEPharmaceutical PreparationsFiscal year ends December 31
Organon & Co.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026
$13.75−0.01 (-0.07%)
Close on Oct 19, 2026
- Market cap
- $3.72B
- P/E (TTM)
- 17.6
- Dividend yield
- 2.47%
Dividends
Dividend declared per share by fiscal year, adjusted for stock splits
Per share, FY2025
$0.34
-69.6% on the prior year
Consecutive increases
0 years
Not raised last year
Dividend yield
2.47%
Latest annual dividend ÷ share price
Payout ratio, FY2025
47.1%
Dividends paid ÷ net income
Dividend history
By fiscal year
| Fiscal year | Per share | Change | Cash paid | Payout ratio |
|---|---|---|---|---|
| FY2025 | $0.34 | -69.6% | $88.00M | 47.1% |
| FY2024 | $1.12 | 0.0% | $297.00M | 34.4% |
| FY2023 | $1.12 | 0.0% | $294.00M | 28.7% |
| FY2022 | $1.12 | +100.0% | $290.00M | 31.6% |
| FY2021 | $0.56 | – | $145.00M | 10.7% |
Ex-dividend and payment dates for each distribution will appear once a dividend calendar source is connected.